This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
The below stocks have been identified as having potential to register bigger than normal share price moves (up or down) today based on the news cited
Barclays (BARC) - Reported Q2 pretax profits had trebled, reaching £1.9bn for the quarter, up from £659m y-o-y, beating analysts' expectations of analysts £1.46bn by 30% as it avoided the heavy restructuring and legal costs that blighted past results and. Closing price 191.52p (Reuters)
Aviva (AV) – Saw a 2% drop in H1 operating profit, £1.44bn against £1.47bn last year, hit by divestments, weaker profits in Canada and weather related claims increasing significantly. EPS +4% to 26.8pp share beating forecasts, on target to hit 5% for the year. It increased its interim dividend by 10% to 9.25pp share. Closing price 495.20p (Reuters)
Rolls-Royce (RR) – Takes an exceptional charge of £554m in respect of the Trent 1000 issues for the period to 2022, although it has upped its guidance for 2018 saying results would be in the upper half of its guidance range and free cash flow would be higher. Closing price 989.20p (Bloomberg / Reuters)
Vedanta Resources (VED) – Agarwal has made a $1bn offer to buy 33.47% of Vedanta, the non-promoter shares valuing the company at $3.07bn. Closing price 819.80p (Bloomberg)
RSA Insurance (RSA) – Sees H1 operating profit fall 15% to £304m from £360m y-o-y due to adverse weather primarily in Canada. Earnings climbed +18%, with the interim dividend climbing +11%. Closing price 640.40p (Reuters)
Sage Group (SGE) - Organic revenue for the full year was +7% higher with Q3 organic revenue +6.8% and 9-month organic revenue +6.5%, net debt increased 3%. Closing price 625.80p (Bloomberg)
(Sources: Company newswires, Bloomberg, CNBC, FT, Reuters, Wall Street Journal)
For more information on any of these individual news items, call into the trading floor
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.
Prepared by Michael van Dulken, Head of Research